INS and hypertensive disorder: METS-IR, a non-insulin-based IR index, was also significantly elevated in diabetics for both Grade II (46.46 vs. 39.88, p = 0.015) and Grade III HTN (51.04 vs. 44.49, p = 0.0009), confirming its robustness in detecting IR across varying BP levels.